ONIDA, FRANCESCO
ONIDA, FRANCESCO
Dipartimento di Oncologia ed Emato-Oncologia
Pneumonia definition in allogeneic hematopoietic cell transplant recipients: Update and challenges in 2024. Recommendations from the EBMT Infectious Diseases Working Party and Practice Harmonization and Guidelines committee
2025 D. Neofytos, P.E. Verweij, D. Averbuch, M. Mikulska, J. Styczynski, J.L. Piñana, S. Cesaro, I. Sanchez-Ortega, R. Greco, F. Onida, I. Yakoub-Agha, P. Ljungman, R. De La Camara, A. Bergeron
The Changing Impact of Human Cytomegalovirus Serology and Infection on Patient Outcome After Allogeneic Hematopoietic Stem Cell Transplantation: An Italian Prospective Multicenter Survey in the Era of Letermovir Prophylaxis
2025 C. Girmenia, P. Chiusolo, G. Marsili, A. Piciocchi, M.C. Micò, R. Greco, G. Porto, F. Galaverna, F. Bonifazi, I. Cutini, M. Malagola, S. Bramanti, A. Busca, A.M. Carella, A. Carotti, A.P. Iori, F. Onida, R. Bono, E. Terruzzi, A. Vacca, A. Rinaldi, I.M. Cavattoni, A. Picardi, M. Faraci, T. Lazzarotto, F. Baldanti, P. Clerici, L. Castagna, M. Martino, F. Ciceri
Urgent need: evidence-based use of donor lymphocyte infusions – Authors' reply
2025 S. Pagliuca, C. Schmid, N. Santoro, F. Simonetta, G. Battipaglia, T. Guillaume, R. Greco, F. Onida, I. Sánchez-Ortega, I. Yakoub-Agha, F. Malard, J. Kuball, M.D. Hazenberg, A. Ruggeri
Diagnostic accuracy of liver stiffness measurement for the diagnosis of veno-occlusive disease/sinusoidal obstruction syndrome after hematopoietic stem cell transplantation (HSCT), the ELASTOVOD STUDY: an investigator-initiated, prospective, multicentre diagnostic clinical trial
2025 F. Ravaioli, A. Colecchia, J. Peccatori, D. Pagliara, A. Grassi, F. Barbato, R. Masetti, B. Sarina, S. Sica, S. Cesaro, C. Nozzoli, G.M. Assanto, L. Prezioso, S. Santarone, F. Saglio, E. Vanni, A. Olivieri, M. Delia, E. Benedetti, F. Zallio, F. Pane, C. Skert, M. Menconi, F. Benedetti, F. De Felice, L. Colecchia, T. Belotti, L.V. Alemanni, M. Ursi, G. Marasco, M. Roberto, A. Vestito, E. Dajti, M. Garcovich, S. Bramanti, D. Taurino, F. Quagliarella, F. Ciceri, A. Prete, A. Pession, D. Festi, N. Null, M. Arpinati, E. Maffini, S. Falcione, R.M. Zagari, Z. Daniele, L. Lazzari, A. Rambaldi, L. Riccardi, V.D. Ruscio, E. Boccieri, M. Falcomer, V. Chiara, V. Vitale, C. Garonzi, F. Vizzutti, U. Arena, A.D. Santis, A. Rinaldi, A. Olivani, D. Vaddinelli, E.D. Lembo, M. Spadea, V. Apolito, D. Chiara, A. Busca, G. Mancini, G. Argalia, P. Carluccio, F. Passerini, A.D. Gangi, P. Rivela, R. Carbone, G. Battipaglia, F. Carobolante, I. Franceschet, F. Patriarca, M. Malagola, R. Varaldo, F. Onida, P. Vincenzo, F. Bonifazi, F. Bonifazi
Non-ICANS neurological complications after CAR T-cell therapies: recommendations from the EBMT Practice Harmonisation and Guidelines Committee
2025 C.E. Graham, R. Velasco, A. Alarcon Tomas, O.P. Stewart, G. Dachy, F. Del Bufalo, M. Doglio, J. Henter, G. Ortí, Z. Peric, C. Roddie, N.W.C.J. Van De Donk, M.J. Frigault, A. Ruggeri, F. Onida, I. Sánchez-Ortega, I. Yakoub-Agha, O. Penack
Less frequent complications following CAR T-cell therapies: hemophagocytic lymphohistiocytosis, graft-versus-host disease, thrombotic microangiopathy, coagulation disorders and secondary malignancies: best practice recommendations from the EBMT Practice Harmonization and Guidelines Committee
2025 G. Ortí, G. Dachy, C.E. Graham, Z. Peric, A. Alarcon, F. Del Bufalo, M. Doglio, J. Henter, C. Roddie, O. Stewart, W.C.J. Van De Donk, R. Velasco, M. Aljurf, A. Ruggeri, F. Onida, I. Sánchez-Ortega, I. Yakoub-Agha, O. Penack
Clinical-genomic profiling of MDS to inform allo-HCT: recommendations from an international panel on behalf of the EBMT
2025 C. Gurnari, M. Robin, L. Adès, M. Aljurf, A. Almeida, F.B. Duarte, E. Bernard, C. Cutler, M.G. Della Porta, T. De Witte, A. Dezern, J. Drozd-Sokolowska, E. Duncavage, P. Fenaux, N. Gagelmann, G. Garcia-Manero, C. Haferlach, T. Haferlach, R. Hasserjian, E. Hellström-Lindberg, M. Jacoby, A. Kulasekararaj, R.C. Lindsley, J.P. Maciejewski, H. Makishima, L. Malcovati, M. Mittelman, A.E. Myhre, S. Ogawa, F. Onida, E. Papaemmanuil, J. Passweg, U. Platzbecker, L. Pleyer, K. Raj, V. Santini, A. Sureda, M. Tobiasson, M.T. Voso, I. Yakoub-Agha, A. Zeidan, M. Walter, N. Kröger, D.P. Mclornan, M. Cazzola
Role of allo-HCT in “nonclassical” MPNs and MDS/MPNs: recommendations from the PH&G Committee and the CMWP of the EBMT
2025 N. Polverelli, J.C. Hernández-Boluda, F. Onida, C. Gurnari, K. Raj, T. Czerw, M. Kenyon, M. Robin, K. Sockel, A. Ruggeri, I. Sánchez-Ortega, D.A. Arber, L. Arcaini, F.B. Duarte, G. Battipaglia, Y. Chalandon, F. Ciceri, N.C.P. Cross, J. Drozd-Sokolowska, V. Funke, N. Gagelmann, N. Gangat, J. Gotlib, P. Guglielmelli, C. Harrison, G. Hobbs, T. Jain, J.D. Khoury, J.J. Kiladjian, N. Kröger, L. Malcovati, M. Martino, R. Mesa, A. Orazi, E. Padron, F. Palandri, F. Passamonti, M.M. Patnaik, N. Pemmaraju, D.H. Radia, A. Reiter, D. Russo, C. Scheid, A. Tefferi, A.M. Vannucchi, D.H. Wiseman, I. Yakoub-Agha, D.P. Mclornan
Posttransplant cyclophosphamide as GVHD prophylaxis in patients receiving mismatched unrelated HCT: the PHYLOS trial
2025 A.M. Raiola, B. Bruno, A.M. Risitano, F. Mosna, I.M. Cavattoni, F. Onida, G. Saporiti, F. Patriarca, M.L. Battista, V. Pavone, A. Mele, P. Chiusolo, S. Sica, B. Loteta, C. Di Grazia, A.M. Carella, D. Salvatore, E. Morello, A. Leoni, L. Giaccone, P. Bernasconi, E. Terruzzi, N. Mordini, C. Borghero, F. Zallio, M. Luppi, A. Grassi, A. Olivieri, E. Piras, N. Sacchi, G. Ciccone, A. Castiglione, E. Degrandi, E. Angelucci, M. Martino, F. Bonifazi
Clinical Impact of Graft Cryopreservation on Allogeneic Stem Cell Transplantation: An Italian, Registry‐Based Study on Behalf of the “Gruppo Italiano Per Il Trapianto di Midollo Osseo, Cellule Staminali Emopoietiche e Terapia Cellulare” (GITMO)
2025 I. Defrancesco, V.V. Ferretti, P. Chiusolo, D. Russo, C. Nozzoli, A. Olivieri, M. Gambella, I.M. Cavattoni, S. Bramanti, S. Santarone, R. Fanin, R. Cairoli, S. Piemontese, M. Parma, F. Onida, A. Busca, L. Castagna, A. Cuoghi, D. Pastore, N. Mordini, F. Benedetti, C. Skert, C. Borghero, A.P. Iori, F. Fagioli, V. Pavone, C. Selleri, S. Cesaro, M. Musso, M. Ladetto, D. Vallisa, P. Carluccio, A. Picardi, M. Tozzi, A. Biffi, G. Milone, M. Faraci, A. Prete, L. Prezioso, A.M. Risitano, F.P. Tambaro, V. Tintori, P. Galieni, F. Pane, C. Zerbi, A. Bianchessi, G. Losi, F. Romano, A. Taurino, E. Oldani, N. Polverelli, F. Bonifazi, M. Martino
BLAST: A Globally Applicable and Molecularly Versatile Survival Model for Chronic Myelomonocytic Leukemia
2025 A. Tefferi, S. Fathima, M. Abdelmagid, A. Alsugair, F. Aperna, M. Rezasoltani, M. Yousuf, A. Natu, C.M. Csizmar, M. Gurney, T.L. Lasho, C.M. Finke, R. Kanagal-Shamanna, D. Hammond, K.S. Chien, A. Bazinet, C.D. Dinardo, T.M. Kadia, A.A. Mangaonkar, N.G. Daver, A.D. Pardanani, G. Borthakur, C.J. Zepeda-Mendoza, K.K. Reichard, R. He, S. Loghavi, F. Passamonti, F. Ravandi, K. Sasaki, D. Larson, G. Garcia-Manero, F. Onida, N. Gangat, G. Montalban-Bravo, M.M. Patnaik
Outcomes of CMML patients undergoing allo‐HCT are significantly worse compared to MDS—a study of the CMWP of the EBMT
2024 A. Rovó, L. Gras, B. Piepenbroek, N. Kröger, H.C. Reinhardt, A. Radujkovic, D. Blaise, G. Kobbe, R. Niityvuopio, U. Platzbecker, K. Sockel, M. Hunault‐berger, J.J. Cornelissen, E. Forcade, J.H. Bourhis, Y. Chalandon, F. Kinsella, S. Nguyen‐quoc, J. Maertens, A. Elmaagacli, N. Mordini, P. Hayden, K. Raj, J. Drozd‐sokolowska, L.C. de Wreede, D.P. Mclornan, M. Robin, I. Yakoub‐agha, F. Onida
Impact of post-transplant cyclophosphamide (PTCy)-based prophylaxis in matched sibling donor allogeneic haematopoietic cell transplantation for patients with myelodysplastic syndrome: a retrospective study on behalf of the Chronic Malignancies Working Party of the EBMT
2024 M.Q. Salas, D. Eikema, L. Koster, J. Maertens, J. Passweg, J. Finke, A.E.C. Broers, Y. Koc, N. Kröger, Z.N. Ozkurt, M.J. Pascual-Cascon, U. Platzbecker, G. Van Gorkom, T. Schroeder, J.L. López-Lorenzo, M. Martino, P. Chiusolo, M. Kaufmann, F. Onida, C. Gurnari, C. Scheid, J. Drozd-Sokolowska, K. Raj, M. Robin, D.P. Mclornan
Clinicopathological definition, management and prognostic value of mogamulizumab‐associated rash and other cutaneous events: A systematic review
2024 G. Avallone, G. Roccuzzo, A. Pileri, C. Agostinelli, C.A. Maronese, C. Aquino, G. Tavoletti, F. Onida, P. Fava, S. Ribero, A.V. Marzano, E. Berti, P. Quaglino, S. Alberti‐violetti
Primary cutaneous, epidermotropic mycosis fungoides-like presentation: critical appraisal and description of two novel cases, broadening the spectrum of ALK+ T-cell lymphoma
2024 G.A. Croci, L. Appio, C. Cecchetti, S. Tabano, S. Alberti-Violetti, E. Berti, D. Rahal, F. Cavallaro, F. Onida, D. Tomasini, E. Todisco
Allogeneic haematopoietic cell transplantation for advanced systemic mastocytosis: Best practice recommendations on behalf of the EBMT Practice Harmonisation and Guidelines Committee
2024 D.P. Mclornan, T. Czerw, G. Damaj, M. Ethell, C. Gurnari, J.C. Hernández-Boluda, N. Polverelli, J. Schwaab, K. Sockel, R. Greco, F. Onida, I. Sánchez-Ortega, G. Battipaglia, C. Elena, J. Gotlib, A. Reiter, J. Rossignol, C. Ustun, P. Valent, I. Yakoub-Agha, D.H. Radia
Management of adult patients with CMML undergoing allo-HCT: recommendations from the EBMT PH&G Committee
2024 F. Onida, N. Gagelmann, Y. Chalandon, G. Kobbe, M. Robin, A. Symeonidis, T.M. de Witte, R.A. Itzykson, M. Jentzsch, U. Platzbecker, V. Santini, G.F. Sanz, C. Scheid, E. Solary, P. Valent, R. Greco, I. Sánchez-Ortega, I. Yakoub-Agha, L. Pleyer
Allogeneic hematopoietic cell transplantation for VEXAS syndrome: results of a multicenter study of the EBMT
2024 C. Gurnari, L. Koster, L. Baaij, M. Heiblig, I. Yakoub-Agha, M. Collin, J. Passweg, C.E. Bulabois, A. Khan, M. Loschi, F. Carnevale-Schianca, E. Crisà, D. Caravelli, J. Kuball, F. Saraceni, A. Olivieri, A. Rambaldi, A.G. Kulasekararaj, P.J. Hayden, M. Badoglio, F. Onida, C. Scheid, F. Franceschini, A. Mekinian, S. Savic, M.T. Voso, J. Drozd-Sokolowska, J.A. Snowden, K. Raj, T. Alexander, M. Robin, R. Greco, D.P. Mclornan
Treatment for First Cytomegalovirus Infection Post–Hematopoietic Cell Transplant in the AURORA Trial: A Multicenter, Double-Blind, Randomized, Phase 3 Trial Comparing Maribavir With Valganciclovir
2024 G.A. Papanicolaou, R.K. Avery, C. Cordonnier, R.F. Duarte, S. Haider, J. Maertens, K.S. Peggs, C. Solano, J.H. Young, M. Fournier, R.A. Murray, J. Wu, D.J. Winston, D. Singhal, J. Sasadeusz, J. Maertans, A. Georgala, D. Selleslag, A. Verlinden, T. Kerre, A. De Becker, S. Haider, A. Wright, D. Wu, R. Vrhovac, C. Cordonnier, A. Berceanu, S. Francois, D. Michonneau, A. Huynh, W. Bethge, M. Kaufmann, M. Stelljes, G. Franke, T. Schmitt, L. Müller, M. Ahlgrimm, J. Niederland, P. Tsirigotis, R. Ram, N. Shemtov, T. Rosenvald-Zuckerman, I. Cutini, A. Busca, F. Onida, C. Tecchio, P. Browett, Y.R. Do, S.H. Kim, A. Ho, L.P. Koh, M.L.V. Lopez, J.L. Jimenez, C.F. Coll, R. De la Camara, C. Solano, A. Mussetti, J.C.V. Llamas, P.B. Suñol, M.J. Chacón, R.F. Duarte, M.A.B. Rodríguez, N. Mueller, H. Ozdogu, G. Gurman, A. Bloor, B. Kishore, K.S. Peggs, D. Milojkovic, K. Orchard, A.G. Toth, M. Koh, R.K. Avery, J. Pisano, G. Alangaden, D.J. Winston, G. Papanicolau, B. Gewurz, F.M. Marty, J.H. Young, P. Hagen, R. Reshef, S. Abedin, P. Shaughnessy, L. Gibson, J.T. Shore, C.R. Bachier, J. Yared, M. Malinis
Harnessing the prognostic potential of PHF6 mutations in chronic myelomonocytic leukemia
2024 F. Onida